Development and progression of diabetic eye disease in Newcastle (1977-1984): rates and risk factors
- PMID: 4015877
- DOI: 10.1111/j.1442-9071.1985.tb00397.x
Development and progression of diabetic eye disease in Newcastle (1977-1984): rates and risk factors
Abstract
A prevalence study of diabetic eye disease was conducted in Newcastle during 1977-1978. Ophthalmoscopic retinopathy was found in 49% of 1210 clinic diabetics, while vision-threatening retinopathy (VTR) (proliferative signs of maculopathy) occurred in 13%. Maculopathy was the commonest cause of visual loss, occurring frequently in subjects with non-insulin-dependent diabetes. This group has now been followed for up to seven years (including 70% at four years); incidence rates for the development of retinopathy and for progression to a vision-threatening stage can now be estimated. The study found that diabetics with no retinopathy developed this at a rate of 8% per year, while only 0.4% per year progressed to VTR. However, once any retinopathy was present, progression to VTR occurred in 6% per year (2% proliferative and 4% maculopathy); and if any retinal signs indicating the presence of capillary closure were noted the rate was 13% per year. These rates are for the group overall: however, certain parameters were found to influence the progression in individual patients. Included were the age at onset and the duration of diabetes, the presence of poor control (particularly in older diabetics on oral agents) or associated nephropathy. An analysis of these data and their implications for routine eye screening of diabetics is presented.
Similar articles
-
Update and implications from the Newcastle diabetic retinopathy study.Aust N Z J Ophthalmol. 1990 Feb;18(1):13-7. doi: 10.1111/j.1442-9071.1990.tb00578.x. Aust N Z J Ophthalmol. 1990. PMID: 2357353
-
A decade-long telemedicine screening program for diabetic retinopathy in the north-east of Italy.J Diabetes Complications. 2017 Aug;31(8):1348-1353. doi: 10.1016/j.jdiacomp.2017.04.010. Epub 2017 Apr 13. J Diabetes Complications. 2017. PMID: 28551296
-
First Incidence and Progression Study for Diabetic Retinopathy in Portugal, the RETINODIAB Study: Evaluation of the Screening Program for Lisbon Region.Ophthalmology. 2015 Dec;122(12):2473-81. doi: 10.1016/j.ophtha.2015.08.004. Epub 2015 Sep 15. Ophthalmology. 2015. PMID: 26383994
-
Epidemiology of proliferative diabetic retinopathy.Diabetes Care. 1992 Dec;15(12):1875-91. doi: 10.2337/diacare.15.12.1875. Diabetes Care. 1992. PMID: 1464243 Review.
-
Screening for and managing diabetic retinopathy: current approaches.Am J Health Syst Pharm. 2007 Sep 1;64(17 Suppl 12):S8-14. doi: 10.2146/ajhp070331. Am J Health Syst Pharm. 2007. PMID: 17720893 Review.
Cited by
-
Prognostic factors for the development and progression of proliferative diabetic retinopathy in people with diabetic retinopathy.Cochrane Database Syst Rev. 2023 Feb 22;2(2):CD013775. doi: 10.1002/14651858.CD013775.pub2. Cochrane Database Syst Rev. 2023. PMID: 36815723 Free PMC article. Review.
-
Diabetic retinopathy is not associated with carbonic anhydrase gene polymorphisms.Mol Vis. 2009 Jun 13;15:1179-84. Mol Vis. 2009. PMID: 19536309 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical